| P50 | author | Michael D. Hill | Q37830493 |
| | Babak S Jahromi | Q38328335 |
| P2093 | author name string | Stuart Hutchison | |
| | William S Tucker | |
| | Brian Chiu | |
| | Kate Holmes | |
| P2860 | cites work | Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens | Q33971158 |
| | Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque | Q34205431 |
| | Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). | Q34312881 |
| | Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project | Q34457169 |
| | Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions | Q35395485 |
| | Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study | Q73549963 |
| | An association between an antibody against Chlamydia pneumoniae and common carotid atherosclerosis. | Q37874374 |
| | Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual | Q37874544 |
| | Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity | Q37874654 |
| | Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries. | Q37874714 |
| | Prospective study of pathogen burden and risk of myocardial infarction or death | Q37875116 |
| | Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. | Q37875642 |
| | Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes | Q37875681 |
| | Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness | Q37876102 |
| | Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study | Q37876105 |
| | Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens | Q37876438 |
| | Chlamydia pneumoniae does not influence atherosclerotic plaque behavior in patients with established carotid artery stenosis | Q37877209 |
| | Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. | Q37877681 |
| | Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden | Q37877684 |
| | Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis | Q37877895 |
| | Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. | Q37878157 |
| | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 |
| | Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension | Q37879204 |
| | Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease | Q37879484 |
| | Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. | Q37879706 |
| | Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. | Q37880753 |
| | Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery | Q37881215 |
| | Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery | Q37882074 |
| | Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 |
| | Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis | Q37882356 |
| | Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 |
| | Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen | Q37882581 |
| | Association of chlamydial infection with cerebrovascular disease | Q37884018 |
| | Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery | Q37886058 |
| | Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q37890128 |
| | Carotid artery duplex scanning | Q39598409 |
| | Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature | Q41691481 |
| | 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels | Q43963397 |
| P433 | issue | 4 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| | Chlamydia pneumoniae | Q62869737 |
| P304 | page(s) | 333-339 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Canadian Journal of Neurological Sciences | Q5030246 |
| P1476 | title | Chlamydia pneumoniae and atherosclerosis following carotid endarterectomy | |
| P478 | volume | 30 | |